(Q37573529)

21 August 2017

1 reference

title

Intravenous immunoglobulin therapy for autoimmune diseases (English)

1 reference

21 August 2017

2

Yehuda Shoenfeld

1 reference

21 August 2017

3

Howard Amital

1 reference

21 August 2017

1

Yoav Arnson

1 reference

21 August 2017

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

42

1 reference

21 August 2017

553-560

1 reference

21 August 2017

6

1 reference

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

21 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Effect of intravenous immunoglobulin in immune thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

What is the contents of the magic draft IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Spontaneous recovery from the Guillain-Barré syndrome is associated with anti-idiotypic antibodies recognizing a cross-reactive idiotype on anti-neuroblastoma cell line antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Therapeutic intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Intravenous immune globulin therapy for neurologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Intravenous immunoglobulins: evolution of commercial IVIG preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Intravenous immunoglobulin: adverse effects and safe administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders. A study of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Adverse effects of intravenous immunoglobulin therapy in 56 patients with autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Intravenous immunoglobulin therapy of antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Current approved options for treating patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Response of vasculitic peripheral neuropathy to intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Use of intravenous immunoglobulin and plasma exchange in neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930902785363

10.1080/08916930902785363

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19657774